Royalty Pharma Plc (RPRX)
56.66
-0.50
(-0.87%)
USD |
NASDAQ |
Oct 05, 16:00
56.64
-0.02
(-0.03%)
After-Hours: 20:00
Royalty Pharma Market Cap : 25.26B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 25.26B |
| October 02, 2026 | 25.48B |
| October 01, 2026 | 25.69B |
| September 30, 2026 | 26.01B |
| September 29, 2026 | 25.95B |
| September 28, 2026 | 26.02B |
| September 25, 2026 | 25.95B |
| September 24, 2026 | 25.98B |
| September 23, 2026 | 25.70B |
| September 22, 2026 | 26.08B |
| September 21, 2026 | 26.05B |
| September 18, 2026 | 26.04B |
| September 17, 2026 | 26.27B |
| September 16, 2026 | 26.06B |
| September 15, 2026 | 26.06B |
| September 14, 2026 | 26.32B |
| September 11, 2026 | 26.13B |
| September 10, 2026 | 26.19B |
| September 09, 2026 | 27.01B |
| September 08, 2026 | 27.01B |
| September 04, 2026 | 28.51B |
| September 03, 2026 | 28.47B |
| September 02, 2026 | 28.13B |
| September 01, 2026 | 27.78B |
| August 31, 2026 | 27.37B |
| Date | Value |
|---|---|
| August 28, 2026 | 27.12B |
| August 27, 2026 | 27.60B |
| August 26, 2026 | 27.55B |
| August 25, 2026 | 27.67B |
| August 24, 2026 | 27.34B |
| August 21, 2026 | 27.33B |
| August 20, 2026 | 27.00B |
| August 19, 2026 | 27.52B |
| August 18, 2026 | 26.61B |
| August 17, 2026 | 26.50B |
| August 14, 2026 | 26.12B |
| August 13, 2026 | 26.10B |
| August 12, 2026 | 26.40B |
| August 11, 2026 | 25.76B |
| August 10, 2026 | 25.84B |
| August 07, 2026 | 25.30B |
| August 06, 2026 | 25.52B |
| August 05, 2026 | 25.74B |
| August 04, 2026 | 25.62B |
| August 03, 2026 | 25.48B |
| July 31, 2026 | 26.04B |
| July 30, 2026 | 26.31B |
| July 29, 2026 | 26.38B |
| July 28, 2026 | 26.73B |
| July 27, 2026 | 26.18B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 485.50B |
| Johnson & Johnson | 609.11B |
| Merck & Co., Inc. | 344.47B |
| Viatris, Inc. | 20.36B |
| ANI Pharmaceuticals, Inc. | 1.667B |
Market Cap Related Metrics
| PE Ratio | 30.16 |
| PS Ratio | 11.74 |
| Price to Book Value | 3.696 |
| Price to Free Cash Flow | 48.61 |
| Price | 56.66 |
| Earnings Yield | 3.32% |
| Operating PE Ratio | 18.84 |
| Normalized PE Ratio | 32.08 |